Ocugen Return On Equity vs. Price To Earning
| OCGN Stock | USD 0.98 0.01 1.03% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (1.56) | Current Value (1.48) | Quarterly Volatility 5.10411844 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.62 | 0.8834 |
|
|
For Ocugen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ocugen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ocugen Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ocugen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ocugen Inc over time as well as its relative position and ranking within its peers.
Ocugen |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.19) | Revenue Per Share 0.018 | Quarterly Revenue Growth 1.353 | Return On Assets (0.48) | Return On Equity (1.03) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ocugen Inc Price To Earning vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Ocugen's current stock value. Our valuation model uses many indicators to compare Ocugen value to that of its competitors to determine the firm's financial worth. Ocugen Inc is rated below average in return on equity category among its peers. It is regarded third in price to earning category among its peers . At this time, Ocugen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ocugen's earnings, one of the primary drivers of an investment's value.Ocugen Price To Earning vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Ocugen |
| = | -1.03 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Ocugen |
| = | (1.81) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Ocugen Price To Earning Comparison
Ocugen is currently under evaluation in price to earning category among its peers.
Ocugen Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Ocugen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ocugen will eventually generate negative long term returns. The profitability progress is the general direction of Ocugen's change in net profit over the period of time. It can combine multiple indicators of Ocugen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 20 K | 21 K | |
| Operating Income | -65.5 M | -62.3 M | |
| Income Before Tax | -63.1 M | -59.9 M | |
| Total Other Income Expense Net | 2.5 M | 2.9 M | |
| Net Loss | -63.1 M | -59.9 M | |
| Income Tax Expense | 536.1 K | 562.9 K | |
| Interest Income | 14.5 K | 13.7 K | |
| Net Loss | -63.1 M | -59.9 M | |
| Non Operating Income Net Other | -279 K | -265.1 K | |
| Net Loss | -73.2 M | -69.6 M | |
| Net Interest Income | -90.8 K | -95.4 K | |
| Change To Netincome | 13.3 M | 14 M | |
| Net Loss | (0.26) | (0.27) | |
| Income Quality | 0.98 | 0.76 | |
| Net Income Per E B T | 1.10 | 1.11 |
Ocugen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Ocugen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ocugen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ocugen's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Ocugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Use Investing Themes to Complement your Ocugen position
In addition to having Ocugen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
To fully project Ocugen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ocugen Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ocugen's income statement, its balance sheet, and the statement of cash flows.